This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


The Use of Thyroid Supplements to Augment Antidepressant Medication

Russell T. Joffe, M.D.

Published: April 1, 1998

Article Abstract

Despite methodological flaws that limit conclusions, a considerable database documents the efficacyof triiodothyronine (T3) as an augmentation strategy for response to various classes of antidepressants.One study suggests that T3 and lithium are of comparable efficacy in antidepressantnonresponders. No clear biochemical or clinical predictors of preferential response to T3 have beenfound. The role of T3 augmentation requires further evaluation, especially with regard to dose andduration

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...